Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

This study has been withdrawn prior to enrollment.
(Gallium is no longer available for the conduct of this study.)
Sponsor:
Collaborator:
Genta Incorporated
Information provided by (Responsible Party):
Scott E Smith, MD, PhD, Loyola University
ClinicalTrials.gov Identifier:
NCT00836173
First received: February 3, 2009
Last updated: March 14, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)